NCT04634487

Brief Summary

Polish registry of takotsubo syndrome

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
45mo left

Started Oct 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Oct 2020Jan 2030

Study Start

First participant enrolled

October 1, 2020

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 18, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
8.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Expected
Last Updated

November 18, 2020

Status Verified

November 1, 2020

Enrollment Period

1 year

First QC Date

October 9, 2020

Last Update Submit

November 12, 2020

Conditions

Takotsubo Syndrome

Outcome Measures

Primary Outcomes (1)

  • Number of participants with in-hospital complications and mortality

    In hospital complications include atrial fibrillation, ventricular tachycardia, ventricular fibrillation, atrioventricular block, cardiogenic shock, cardiac arrest

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Number of participants with complications with echocardiography

    through study completion, an average of 1 year

Interventions

No interventionOTHER

No intervention

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalised with takotsubo syndrome in Poland

You may qualify if:

  • all patients with takotsubo syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Warsaw

Warsaw, Poland

RECRUITING

MeSH Terms

Conditions

Takotsubo Cardiomyopathy

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesVentricular Dysfunction, LeftVentricular Dysfunction

Central Study Contacts

Monika Budnik, PhD

CONTACT

+48225991958mbudnik@wum.edu.pl

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2020

First Posted

November 18, 2020

Study Start

October 1, 2020

Primary Completion

October 1, 2021

Study Completion (Estimated)

January 1, 2030

Last Updated

November 18, 2020

Record last verified: 2020-11

Locations

PL(1)